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ABSTRACT
Leprosy, also known as Hansen disease, is an uncommon
chronic disease caused by the slowly growing acid-fast
bacilli, Mycobacterium leprae. Leprosy has tropism for
peripheral nerves and skin and can also be found in the
upper respiratory tract, eyes, and nasal mucosa. When
left untreated, there can be considerable nerve damage
resulting in paralysis, blindness, and the crippling of
hands and feet. Although infrequent in the United
States, leprosy has been diagnosed in patients exposed
to armadillos, an animal reservoir. We describe an
80-year-old man who presented with a 6-year history
of chronic erythematous, macular rash, and progressive
symmetric sensory motor neuropathy. Initially, it was
thought that the patient had an eczematous rash;
however, he was later diagnosed with polar lepromatous
disease owing to findings from a sural nerve biopsy.
When results of clinical examination and skin biopsy are
inconclusive, use of a peripheral nerve biopsy may help
confirm leprosy.
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INTRODUCTION
Leprosy, also known as Hansen disease, is caused by
the slowly growing acid-fast bacilli, Mycobacterium
leprae, infecting the skin and peripheral nerves.
Most leprosy cases occur in developing countries.
Countries with high incidence rates include India,
Brazil, Indonesia, Bangladesh, and Nigeria. In the
United States (US), a few hundred new diagnoses are
reported each year. About 75% of affected patients
immigrated to the US or have traveled to endemic
countries. It is suggested that leprosy is spread
through the respiratory route, although the means of
transmission are not fully understood. In the US, leprosy
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is also a zoonotic disease, passed between humans and
armadillos.1 Other risk factors include old age, genetic
predisposition, immunosuppression, and close contact
with known cases.2
Leprosy is classified into the following categories:
tuberculoid, borderline tuberculoid, mid-borderline,
borderline lepromatous, lepromatous, and
indeterminate. Patients with a high degree of cellmediated immunity and delayed hypersensitivity present
as tuberculoid with relatively few well-demarcated
lesions. Patients with no apparent resistance
to Mycobacterium leprae present as lepromatous with
many poorly demarcated lesions. Patients in the other
categories can present with a spectrum of symptoms
between tuberculoid and lepromatous. Early physical
examination findings include: hypopigmented or
reddish skin patches, diminished sensation or loss
of sensation in involved areas, paresthesias, painless
wounds or burns, and tender enlarged peripheral nerves.
Neuropathy and ophthalmic injury can also occur. The
diagnosis is established when at least one of these
physical findings is present, and skin biopsy findings
(obtained from the leading edge of the skin lesion)
confirm the presence of acid-fast bacilli in a cutaneous
nerve.2 Alternatively, sural nerve biopsy findings can
confirm diagnosis.
When other diagnoses have been ruled out, leprosy
should be in the differential for patients who present
with skin manifestations and progressive neuropathy.2
Early diagnosis and a full course of treatment are critical
for preventing lifelong neuropathy and disability. Often,
diagnosis is delayed owing to potentially fragmented
care and unfamiliarity with the rare disease in the US.
We describe an older man who was diagnosed with
leprosy 6 years after onset of symptoms.

CASE REPORT
An 80-year-old Hispanic man, born and residing in the
US, presented for an assessment of hand contracture.
His medical history included Parkinson disease. Before
retirement, he had traveled for work in South America,
including Brazil and Mexico. The patient did not recall
any close contacts with individuals who may have had
Hansen disease, and thus he was unsure about the
source.
Six years before his current presentation, the patient
developed an erythematous macular rash on his
extremities, which progressed to his trunk and back.
He did not recall if there was hypoesthesia associated
with the lesions. His skin lesions were initially diagnosed
as eczema. After 3 years of failed treatment, skin
biopsies were performed revealing superficial and
deep perivascular lymphohistiocytic infiltrates that
were suggestive of infection. Immunohistochemical
stains were negative for Treponema pallidum
but showed rod-shaped microorganisms in areas
containing histiocytes. Acid-fast bacilli smear and
culture were negative for mycobacterium. Fungal and
routine bacterial cultures were negative. Treponema
pallidum antibody and QuantiFERON Gold were both
nonreactive. Subsequently, the diagnosis of leprosy
was not considered definitive at that time. The lesions
did not resolve and continued to be nonpruritic and
hypoesthetic.

The patient developed numbness (associated with
tingling and paresthesias) in both upper and lower
extremities. At that time, electromyography findings
were normal. He was seen at multiple facilities during
the next few years for treatment of progressive
sensorimotor neuropathy in all extremities due to
unclear causes before progressing to his current level
of disability. Other symptoms included the chronic
rash, mild left lagophthalmos, madarosis, and a
nonobstructive lesion on the left vocal fold.
He was referred to an orthopaedic surgeon (EAM)
and noted the following concerns: lack of sensation
in his lower extremities distal to his knees, minimal
sensation in his hands to his elbows, contractures
of both of his hands, and left foot drop. Findings of
sural nerve biopsy using Fite staining revealed many
acid-fast organisms, severe intraneural mononuclear
inflammation, destruction of axon and myelin, and
involvement of the blood vessel wall with luminal
narrowing but without fibrinoid necrosis. Findings
of 16S ribosomal molecular testing were positive
for Mycobacterium leprae complex; however, no
Mycobacterium tuberculosis was detected. There were
no distinct granulomas on nerve biopsy findings. Biopsy
results were consistent with polar lepromatous disease
(Figures 1A through 1D).
It was determined that the hand contractures
were likely caused by considerable imbalance
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Figure 1. Various stains of the sural nerve biopsy. A) Haemotoxylin and eosin stain shows axonal and myelin
destruction and blood vessel wall involvement with luminal narrowing but without fibrinoid necrosis. Axons, light
blue; blood vessels, light pink; and epithelium enclosing pink-red stained lumen. B) Cluster of differentiation
68 (CD68) immunohistochemical stain shows dark brown CD68 staining of intracellular granules in monocytes,
representing intraneural mononuclear inflammation. C) Sevier-Munger silver stain shows differentiation of
histological features within the nerve tissue. Axons, black; myelin sheath, light brown; and collagen and muscle,
brown. D) Fite acid-fast stain, revealing Mycobacterium leprae as indicated by pink clusters of bacilli.
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involving severe weakness of his intrinsic muscles. At
presentation to our clinic, the patient had developed
contractures of multiple fingers. After discussing
treatment options with the patient, surgical treatment
was not recommended because of uncertainty that the
benefits would outweigh the risks. He was subsequently
referred to physical therapy. Recommendations were
considered for immunosuppressive therapy to prevent
further nerve damage.
Shortly after definitive diagnosis, the patient
was prescribed antibiotics by the infectious disease
specialist (KSS). After consultation with the National
Hansen’s Disease Program in Louisiana, the oral
regimen was started and included 500 mg of
clarithromycin extended-release tablets daily, 100 mg of
minocycline daily, and 600 mg of rifampin monthly to
be taken for at least 1 year. The patient was not a risk to
infect others, thus he did not require decreased contact
with the public.

DISCUSSION
Leprosy should be considered as a diagnosis in
patients with skin lesions, enlarged nerves, and sensory
loss. Loss of sensory perception occurs in the early
stages of leprosy. Preventing or minimizing injury
to peripheral nerves is a major goal of treatment;
therefore, assessment of peripheral nerves is essential.2
In a prospective study of early neuropathy diagnosis
in leprosy, sensory nerve conduction and warmth
perception were the earliest and most frequently
affected tests.3
Nerve trunks involved include the ulnar and median
nerves, common peroneal nerve, posterior tibial nerve,
facial nerve, radial cutaneous nerve, and great auricular
nerve. Deficits associated with the involved nerve
trunks include claw hand, foot drop, claw toes, plantar
insensitivity, and lagophthalmos. Nerve biopsy findings
are important in confirming the diagnosis of leprosy,
usually from the sural, superficial radial, or dorsal
branch of the cubital nerves. Histopathological features
of leprosy lesions in the skin and peripheral nerve may
have discrepancies. Biopsy is also useful for evaluating
the effectiveness of treatment.2
On sural nerve biopsy, polar lepromatous leprosy
is characterized by firm, cord-like thickening of the
peripheral nerves, which is the result of extensive
fibrosis. There is extensive loss of nerve fiber and
an increase in endoneurial collagen. Infiltration with
foamy macrophages and an absence of lymphocytes
are prominent. The perineurium may be thick and
extensively multilayered. The subperineurial area may
contain a granular proteinaceous matrix and pockets
of collagen. Numerous bacilli are seen in the foamy
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Figure 2. Transverse section of full thickness of the sural
nerve biopsy from a comparison case of borderline
lepromatous leprosy, showing varying degree of
involvement of nerves. All seven fascicles seen in
two bundles show lymphocytes predominantly in the
endoneurial area (E). Degree of infiltration varies from
mild (m) to severe (s). Density of lymphocytes is higher
below the perineurium (P) and around the blood vessels
(V). Mild lymphocytic infiltrate is also seen around
several of the blood vessels in the epi-fascicular area
(Fite stain × 4). Interfascicular perineurium (IFP).5
macrophages, and Schwann cells are frequently packed
in clusters or bundles. In the absence of any infiltrating
cells, it is common to find Schwann cells loaded with
bacilli in a clinically cord-like nerve from an untreated
polar lepromatous case (Figures 2).4,5 Although fibrosis
in our patient’s specimen was mild to moderate and
CD8 positive lymphocytes were present in numbers
nearly equivalent to those of macrophages, the
quantity of organisms was quite high and the histologic
appearance appeared more consistent with a less
inflammatory category of disease.
Our patient presented with symptoms of chronic
lepromatous leprosy. He had notable physical deficits
because of the delay in diagnosis due to fragmented
care and the rareness of this disease. His skin lesions
and neuropathy did not have a conclusive diagnosis
until the findings of a sural nerve biopsy. Although risks
of sural nerve biopsies include infection and increased
pain, the biopsy is recommended in patients with
considerably progressive symptoms, dense sensory
loss in the associated nerve territory, and inconclusive
findings from less invasive testing such as skin biopsies.6
Notably, obtaining a skin biopsy presents minimal risk to
the patient and should thus be obtained early. However,
findings of sural nerve biopsy can prove helpful when
skin biopsy results are inconclusive in patients with
progressive neurological deficits.
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